This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AUA Joins IPAB Repeal Coalition In Endorsing The "Protecting Seniors' Access To Medicare Act Of 2013"

Coalition also renews commitment to repeal IPAB

LINTHICUM, Md., Jan. 23, 2013 /PRNewswire-USNewswire/ -- The American Urological Association (AUA) today joined 25 other medical organizations in announcing support of the Protecting Seniors' Access to Medicare Act, introduced by Reps. Phil Roe, M.D. (R-TN) and Allyson Schwartz (D-PA). The bipartisan bill would repeal the Independent Payment Advisory Board (IPAB).

Established by the Affordable Care Act, the IPAB is an unelected and unaccountable body of 15 persons tasked with developing ways to reduce Medicare spending and is slated to begin work as early as April 30, 2013. As presently structured, the IPAB cannot include any practicing physicians, presenting a worrisome absence of insight into the needs of patients and physicians alike. Alarmingly, the board is not subject to administrative or judicial review and lacks the typical Congressional oversight requirements of transparent hearings, debate and meaningful opportunities for critical stakeholder input. Any IPAB proposal automatically carries the effect of law unless Congress acts within an extremely limited statutory "fast track" time frame, or unless three-fifths of the Senate votes to override the board. If the IPAB fails to offer a proposal or never becomes operational, its power to cut Medicare spending mandatorily is placed solely in the hands of the Secretary of the U.S. Department of Health and Human Services.   

"The IPAB has the potential to be far-reaching and have devastating effects for patients and physicians, who are already struggling under reimbursement cuts from the sustainable growth rate (SGR) formula," said Dr. David F. Penson, M.D., MPH, AUA Health Policy Chair. "Meaningful healthcare reform is about more than simply cutting costs -- it's about generating savings through long-term delivery system reforms."

"We applaud and thank Dr. Roe and Congresswoman Schwartz for their leadership on this issue and we hope that this legislation is a priority in the coming months."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs